The acute course of COVID-19 is variable and ranges from asymptomatic infection to
fulminant respiratory failure. Patients recovering from COVID-19 can have persistent …

Background: It has remained a concern whether any long-term pulmonary sequelae exist for
COVID-19 survivors. Methods: Forty-one patients (22 men and 19 women, 50±14 years) …

Introduction. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a highly
contagious disease, and its first outbreak was reported in Wuhan, China. A coronavirus …

Background After the 2002/2003 severe acute respiratory syndrome outbreak, 30% of
survivors exhibited persisting structural pulmonary abnormalities. The long-term pulmonary …

Background A proportion of coronavirus disease 2019 (COVID-19) survivors experience
persistent dyspnoea without measurable impairments in lung function. We performed a …

In this retrospective study, chest CTs of 121 symptomatic patients infected with coronavirus
disease-19 (COVID-19) from four centers in China from January 18, 2020 to February 2 …

The long-term sequelae of coronavirus disease 2019 (COVID-19) are still unknown.
Lessons from past viral epidemics reveal that, after recovery, patients with viral pulmonary …

Background Chest CT is used to assess the severity of lung involvement in COVID-19
pneumonia. Purpose To determine the change in chest CT findings associated with COVID …

We evaluated pulmonary sequelae in COVID-19 survivors by quantitative inspiratory–
expiratory chest CT (QCT) and explored abnormal pulmonary diffusion risk factors at the 6 …

Background The chest CT manifestations of COVID-19 from hospitalization to
convalescence after 1 year are unknown. Purpose To assess chest CT manifestations of …